Today: 6 April 2026
Browse Category

NASDAQ:STOK 24 February 2026

Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics shares dropped 1.2% to $35.80 in early premarket trading Tuesday, after a 5.7% gain the previous session. Wolfe Research began coverage with an “Outperform” rating and a $40 price target. Investors are watching for updates on the company’s Phase 3 Dravet syndrome trial with Biogen. About 21.6% of Stoke’s float is sold short, according to MarketBeat.

Stock Market Today

  • Tough U.S. Job Market Leaves Young Adults Struggling to Secure Internships
    April 6, 2026, 6:29 AM EDT. The U.S. job market's sharp slowdown has made securing internships increasingly difficult for young adults, a vital step for early career growth. Despite high application volumes, many entry-level roles demand several years of experience, putting fresh graduates like Muneeb Iqbal under strain. Internship postings dropped last year, slipping below 2019 levels, with pharmacy and marketing being top sectors. Competition soared, with tech internships receiving an average of 273 applications each. Experts warn fewer opportunities now could dampen future hiring prospects, as internships strongly predict post-graduation employment. Students like Enrique Torres express stress over limited options, highlighting the widening challenge for new graduates.
Go toTop